Drug
HS-10383 clinical trials
Also written HS-10383.
Keep track of what changes. Save the HS-10383 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- HS-10383
- 3
Studies by the year they started
3 studies that test it; most in 2022 (1)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses HS-10383 is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)Not yet recruitingPhase 2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06246565Written as HS-10383
- A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383Status unknownPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06092983Written as HS-10383
- First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383Status unknownPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT05429723Written as HS-10383